These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12127842)

  • 1. What constitutes best medical therapy for peripheral arterial disease?
    Burns P; Lima E; Bradbury AW
    Eur J Vasc Endovasc Surg; 2002 Jul; 24(1):6-12. PubMed ID: 12127842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second best medical therapy.
    Burns P; Lima E; Bradbury AW
    Eur J Vasc Endovasc Surg; 2002 Nov; 24(5):400-4. PubMed ID: 12435338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM
    J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.
    Kobayashi T; Parikh SA; Giri J
    Curr Cardiol Rep; 2015 Oct; 17(10):86. PubMed ID: 26280273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary and optimal medical management of peripheral arterial disease.
    Tattersall MC; Johnson HM; Mason PJ
    Surg Clin North Am; 2013 Aug; 93(4):761-78, vii. PubMed ID: 23885930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for peripheral artery disease.
    Duprez DA
    Expert Opin Pharmacother; 2007 Jul; 8(10):1465-77. PubMed ID: 17661729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of peripheral arterial disease.
    Regensteiner JG; Hiatt WR
    Clin Cornerstone; 2002; 4(5):26-40. PubMed ID: 12425182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease.
    Hirsch AT; Treat-Jacobson D; Lando HA; Hatsukami DK
    Vasc Med; 1997; 2(3):243-51. PubMed ID: 9546975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral arterial disease in the elderly: recognition and management.
    Aronow H
    Am J Cardiovasc Drugs; 2008; 8(6):353-64. PubMed ID: 19159122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for peripheral arterial disease.
    Simmons A; Steffen K; Sanders S
    Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of Canadian Vascular Surgeons Toward Pharmacologic Risk Reduction in Patients with Peripheral Artery Disease: 2018 Update.
    Li B; Salata K; de Mestral C; Hussain MA; Aljabri BA; Lindsay TF; Verma S; Al-Omran M
    Ann Vasc Surg; 2019 Jul; 58():166-173.e4. PubMed ID: 30771465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.
    Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D
    Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral arterial disease.
    Aronow WS
    Geriatrics; 2007 Jan; 62(1):19-25. PubMed ID: 17223718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.